Ikena Oncology Inc

NASDAQ:IKNA   3:59:50 PM EDT
3.70
-0.02 (-0.54%)
Earnings Announcements

Ikena Oncology Reports Q4, Full Year 2021 Financial Results

Published: 03/17/2022 11:25 GMT
Ikena Oncology Inc (IKNA) - Ikena Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update.
Ikena Oncology Inc - Cash Runway Through First Half 2024.
Ikena Oncology Inc Qtrly Net Income per Share Attributable to Common Stockholders - Diluted$0.07.
Revenue is expected to be $3.97 Million
Adjusted EPS is expected to be -$0.47

Next Quarter Revenue Guidance is expected to be $4.28 Million
Next Quarter EPS Guidance is expected to be -$0.50

More details on our Analysts Page.